Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer

To evaluate regional and temporal changes in apparent diffusion coefficient (ADC) and T2 relaxation during radiation therapy (RT) in patients with low and intermediate risk localized prostate cancer.

[1]  B. Fallone,et al.  Monitoring T2 and ADC at 9.4 T following fractionated external beam radiation therapy in a mouse model , 2010, Physics in medicine and biology.

[2]  B. Fallone,et al.  Temporal and dose dependence of T2 and ADC at 9.4 T in a mouse model following single fraction radiation therapy. , 2009, Medical physics.

[3]  Masoom A. Haider,et al.  Change in diffusion weighted MRI during liver cancer radiotherapy: Preliminary observations , 2009, Acta oncologica.

[4]  D. Kuban,et al.  Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease? , 2008, International journal of radiation oncology, biology, physics.

[5]  D P Dearnaley,et al.  Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. , 1999, International journal of radiation oncology, biology, physics.

[6]  J. Geitung,et al.  Prostate magnetic resonance imaging: Multiexponential T2 decay in prostate tissue , 2008, Journal of magnetic resonance imaging : JMRI.

[7]  C. V. van Gils,et al.  Influence of antiflatulent dietary advice on intrafraction motion for prostate cancer radiotherapy. , 2011, International journal of radiation oncology, biology, physics.

[8]  C. N. Coleman,et al.  Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. , 2006, Cancer research.

[9]  R. Kurland.  Strategies and tactics in NMR imaging relaxation time measurements. I. Minimizing relaxation time errors due to image noise—the ideal case , 1985, Magnetic resonance in medicine.

[10]  N. Clarke,et al.  Late tissue effects following radiotherapy and neoadjuvant hormone therapy of the prostate measured with quantitative magnetic resonance imaging. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  R L Somorjai,et al.  Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: a histopathologic study of diagnostic validity. , 2001, International journal of radiation oncology, biology, physics.

[12]  Gary P Liney,et al.  Correlation of ADC and T2 Measurements With Cell Density in Prostate Cancer at 3.0 Tesla , 2009, Investigative radiology.

[13]  M. van Leerdam,et al.  A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy. , 2012, International journal of radiation oncology, biology, physics.

[14]  R M Henkelman,et al.  Continuous distributions of NMR relaxation times applied to tumors before and after therapy with X‐rays and cyclophosphamide , 1988, Magnetic resonance in medicine.

[15]  Stephan E Maier,et al.  Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. , 2006, Magnetic resonance imaging.

[16]  Gary Liney,et al.  Correlation of diffusion‐weighted magnetic resonance data with cellularity in prostate cancer , 2009, BJU international.

[17]  D. Kuban,et al.  Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure. , 2006, Urology.

[18]  B. Issa,et al.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo‐planar imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[19]  Masoom A Haider,et al.  Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[20]  C. Thomsen,et al.  In vivo estimation of relaxation processes in benign hyperplasia and carcinoma of the prostate gland by magnetic resonance imaging. , 1987, Magnetic Resonance Imaging.

[21]  Bradford A Moffat,et al.  The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. , 2006, Neoplasia.

[22]  G P Liney,et al.  In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI. , 1997, Magnetic resonance imaging.

[23]  C. Ménard,et al.  Image guided dose escalated prostate radiotherapy: still room to improve , 2009, Radiation oncology.

[24]  J R MacFall,et al.  An analysis of noise propagation in computed T2, pseudodensity, and synthetic spin-echo images. , 1986, Medical physics.

[25]  O. Kilickesmez,et al.  Diffusion-weighted MRI of urinary bladder and prostate cancers. , 2009, Diagnostic and interventional radiology.

[26]  H. Huisman,et al.  Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.

[27]  Masoom A Haider,et al.  Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. , 2007, AJR. American journal of roentgenology.

[28]  Baris Turkbey,et al.  Accelerated T2 mapping for characterization of prostate cancer , 2011, Magnetic resonance in medicine.

[29]  C. Ménard,et al.  Practical approaches to proteomic biomarkers within prostate cancer radiotherapy trials , 2008, Cancer and Metastasis Reviews.

[30]  Deanna L Langer,et al.  Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. , 2008, Radiology.

[31]  Jae Young Lee,et al.  Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. , 2009, Radiology.

[32]  Peter Gibbs,et al.  Comparison of quantitative T2 mapping and diffusion‐weighted imaging in the normal and pathologic prostate , 2001, Magnetic resonance in medicine.

[33]  Olivier Rouvière,et al.  Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor--correlation with biopsy findings. , 2004, Urology.

[34]  S. Haker,et al.  Carr-Purcell-Meiboom-Gill imaging of prostate cancer: quantitative T2 values for cancer discrimination. , 2009, Magnetic resonance imaging.

[35]  J. Kurhanewicz,et al.  Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. , 2004, Radiology.

[36]  G. Lockwood,et al.  A cinematic magnetic resonance imaging study of milk of magnesia laxative and an antiflatulent diet to reduce intrafraction prostate motion. , 2010, International journal of radiation oncology, biology, physics.

[37]  D. Beyersdorff,et al.  MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[38]  C. Hutchinson,et al.  Benign prostatic hyperplasia: Evaluation of T1, T2, and microvascular characteristics with T1‐weighted dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.

[39]  Peter Choyke,et al.  Challenges in clinical prostate cancer: role of imaging. , 2009, AJR. American journal of roentgenology.

[40]  David Jaffray,et al.  Clinical prostate T2 quantification using magnetization‐prepared spiral imaging , 2010, Magnetic resonance in medicine.

[41]  C. Meyer,et al.  Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Evans,et al.  Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. , 2010, Radiology.

[43]  Yousef Mazaheri,et al.  MRI of the prostate: Clinical relevance and emerging applications , 2011, Journal of magnetic resonance imaging : JMRI.

[44]  R. Pötter,et al.  The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. , 2002, International journal of radiation oncology, biology, physics.

[45]  Yanlei Li,et al.  Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation. , 2009, Clinical radiology.

[46]  M. V. van Herk,et al.  Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). , 2005, International journal of radiation oncology, biology, physics.

[47]  G. Weinstein,et al.  Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and Neck , 2009, Clinical Cancer Research.

[48]  P. Price,et al.  Functional CT Imaging of the Acute Hyperemic Response to Radiation Therapy of the Prostate Gland: Early Experience , 2001, Journal of computer assisted tomography.